These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15733522)

  • 1. Interferon-induced depression: prevalence and management.
    Scalori A; Pozzi M; Bellia V; Apale P; Santamaria G; Bordoni T; Redaelli A; Avolio A; Parravicini P; Pioltelli P; Roffi L
    Dig Liver Dis; 2005 Feb; 37(2):102-7. PubMed ID: 15733522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of escitalopram prophylaxis during antiviral treatment for chronic hepatitis C in patients with a history of intravenous drug use and depression.
    Hotho DM; Bezemer G; Hansen BE; Van Gool AR; de Knegt RJ; Janssen HL; Veldt BJ
    J Clin Psychiatry; 2014 Oct; 75(10):1069-77. PubMed ID: 25188436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression.
    Schäfer A; Scheurlen M; Seufert J; Keicher C; Weissbrich B; Rieger P; Kraus MR
    J Hepatol; 2010 Jan; 52(1):10-5. PubMed ID: 19897271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression.
    Kraus MR; Schäfer A; Al-Taie O; Scheurlen M
    J Viral Hepat; 2005 Jan; 12(1):96-100. PubMed ID: 15655055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.
    Schaefer M; Hinzpeter A; Mohmand A; Janssen G; Pich M; Schwaiger M; Sarkar R; Friebe A; Heinz A; Kluschke M; Ziemer M; Gutsche J; Weich V; Halangk J; Berg T
    Hepatology; 2007 Oct; 46(4):991-8. PubMed ID: 17668880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
    Vignau J; Karila L; Costisella O; Canva V
    Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.
    Neri S; Bertino G; Petralia A; Giancarlo C; Rizzotto A; Calvagno GS; Mauceri B; Abate G; Boemi P; Di Pino A; Ignaccolo L; Vadalà G; Misseri M; Maiorca D; Mastrosimone G; Judica A; Palermo F
    J Clin Gastroenterol; 2010 Oct; 44(9):e210-7. PubMed ID: 20838237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norepinephrine-enhancing antidepressant exposure associated with reduced antiviral effect of interferon alpha on hepatitis C.
    Fialho R; Burridge A; Pereira M; Keller M; File A; Tibble J; Whale R
    Psychopharmacology (Berl); 2016 May; 233(9):1689-94. PubMed ID: 25971875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression.
    Udina M; Navinés R; Egmond E; Oriolo G; Langohr K; Gimenez D; Valdés M; Gómez-Gil E; Grande I; Gratacós M; Kapczinski F; Artigas F; Vieta E; Solà R; Martín-Santos R
    Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26721949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors in the context of hepatitis C infection: reexamining the risks of bleeding.
    Martin KA; Krahn LE; Balan V; Rosati MJ
    J Clin Psychiatry; 2007 Jul; 68(7):1024-6. PubMed ID: 17685737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
    Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Andrzej K
    Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Side effects of interferon therapy for chronic hepatitis C].
    Arase Y
    Nihon Rinsho; 2006 Jul; 64(7):1363-7. PubMed ID: 16838657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar patients can safely and successfully receive interferon-based hepatitis C antiviral treatment.
    Kelly EM; Corace K; Emery J; Cooper CL
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):811-6. PubMed ID: 22495398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule].
    Horváth G; Tolvaj G; Halász T; Stotz G
    Orv Hetil; 2007 Aug; 148(33):1545-50. PubMed ID: 17686672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Incidence of Depression during Interferon-Based Antiviral Therapy in Chronic Hepatitis C Patients in the Republic of Korea.
    Baeg JY; Kim IH; Seo SY; Kim YS; Jung EU; Cho J; Chung JW; Jang ES; Kim JW; Jeong SH
    Gut Liver; 2017 May; 11(3):426-433. PubMed ID: 28335101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches.
    Asnis GM; De La Garza R
    J Clin Gastroenterol; 2006 Apr; 40(4):322-35. PubMed ID: 16633105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Singin' the blues: the downside of hepatitis C virus treatment.
    Bini EJ
    Am J Gastroenterol; 2007 Nov; 102(11):2434-6. PubMed ID: 17958756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C.
    de Knegt RJ; Bezemer G; Van Gool AR; Drenth JP; Hansen BE; Droogleever Fortuyn HA; Weegink CJ; Hengeveld MW; Janssen HL
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1306-17. PubMed ID: 21999489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal effects of selective serotonin reuptake inhibitor therapy and cytokine-related depression on hepatitis C viral logs during antiviral therapy.
    Sims OT; Whalen CC; Nackerud LG; Bride BE
    J Clin Psychopharmacol; 2014 Feb; 34(1):80-4. PubMed ID: 24135839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of psychopathological outcome during peg-interferon and ribavirin therapy in patients with chronic HCV-correlated hepatitis.
    Dell'Osso B; Prati G; Palazzo MC; Rumi MG; Cavallaro F; Aghemo A; Colombo M; Altamura AC
    J Interferon Cytokine Res; 2013 Jan; 33(1):9-14. PubMed ID: 23276143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.